insuman basal 100 iu/ml suspension for injection
sanofi-aventis kenya p.o box 20337 - 00200 nairobi kenya - recombinant human insulin (isophane insulin - suspension for injection - 100 iu/ml - insulins and analogues for injection
insuman comb 30, 3ml cartridge suspension for injection in cartridge
sanofi-aventis kenya p.o box 20337 - 00200 nairobi kenya - insulin human - suspension for injection in cartridge - 100 iu/ml - insulins and analogues for injection
insuman rapid 100 iu/ml, vial solution for injection
sanofi-aventis kenya p.o box 20337 - 00200 nairobi kenya - insulin human - solution for injection - 100 iu/ml - insulins and analogues for injection fast-acting
insuman combo 30/70
sanofi aventis south africa (pty) ltd - soluble insulin; isophane insulin - suspension - each 1ml suspension contains; biphasic isophane insulin human with 30% soluble insulin and 70% isophane insulin 100 iu
insuman rapid
sanofi aventis south africa (pty) ltd - insulin - solution - each 10 ml solution contains; insulin human 1 000,0 iu
insuman rapid cartridge
sanofi-aventis sa (pty) ltd - insulin human - solution for injection - each 1ml contains; human insulin 100 i.u
insuman comb 30 cartridge
sanofi-aventis sa (pty) ltd - insulin human - suspension for injection - each 1ml suspension contains; biphasic isophane insulin human with 30% soluble insulin and 70% isophane insulin 100 iu
insuman basal
sanofi-aventis south africa (pty) ltd - recombinant insulin (isophane insulin) - injection - each vial contains 5 ml of suspension for injection, equivalent to 500 iu insulin. one iu corresponds to 0.035 mg of anhydrous h
insulin human winthrop
sanofi-aventis deutschland gmbh - insulin human - diabetes mellitus - drugs used in diabetes - diabetes mellitus where treatment with insulin is required. insulin human winthrop rapid is also suitable for the treatment of hyperglycaemic coma and ketoacidosis, as well as for achieving pre-, intra- and postoperative stabilisation in patients with diabetes mellitus.